PMID: 42467120

Differential NAD + availability may drive asymmetric SIRT7 activity in tumor and immune cells.

Lagunas-Rangel Francisco Alejandro

Molecular biology reports · 2026

Vol. 53, Issue 1

This entry links to third-party literature. For research use only.

SirtuinsNADHumansAnimalsTumor MicroenvironmentNeoplasmsMetabolic Reprogramming

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.

Differential NAD&#x2009;+&#x2009;availability may drive asymmetric SIRT7 activity in tumor and immune cells.